Internal Medicine, Nephrology · Seattle, WA
NPI
1154642643
Since 2010
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
515 Minor Ave
Seattle, WA, 98104
Phone (206) 386-9500
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
4,260 services
Medicare patients, 2024
290
Average age 73
Drug cost, 2024
$1.7M
3,013 prescriptions
Company payments, 2025
$100K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Osama Amro was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 3,200 times for 11 patients. In total Osama Amro billed 4,260 services in 19 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 3,200 | 11 | $2.26 | $7,241 |
| 99214 Office E&M - Established | Office | 196 | 145 | $100.06 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 153 | 53 | $99.08 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 140 | 49 | $66.23 | $9,272 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 137 | 122 | $13.48 | $1,847 |
| 90962 ESRD Related Services (not dialysis) | Office | 134 | 34 | $169.29 | $23K |
| 90961 ESRD Related Services (not dialysis) | Office | 70 | 21 | $241.83 | $17K |
| 99215 Office E&M - Established | Office | 45 | 30 | $133.23 | $5,995 |
| 99442 Telephone Services | Office | 33 | 27 | $69.58 | $2,296 |
| 96372 Injection Administration | Office | 26 | 11 | $10.89 | $283 |
| 99223 Hospital E&M - Initial | Facility | 19 | 19 | $138.29 | $2,628 |
By year: 2022 $165K for 4,543 services; 2023 $142K for 4,776 services; 2024 $121K for 4,260 services.
Medicare prescription drug claims, 2024
In 2024, the drug Osama Amro prescribed most often to Medicare patients was Calcitriol, with 282 prescriptions and refills. In total Osama Amro wrote 3,013 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 282 | 648 | 70 | $4,852 |
| Furosemide Generic | 257 | 647 | 85 | $1,349 |
| Farxiga Dapagliflozin Propanediol | 229 | 487 | 55 | $262K |
| Losartan Potassium Generic | 219 | 610 | 74 | $1,914 |
| Amlodipine Besylate Generic | 217 | 581 | 74 | $1,669 |
| Hydralazine Hcl Generic | 118 | 254 | 33 | $1,883 |
| Tamsulosin Hcl Generic | 106 | 298 | 36 | $1,742 |
| Carvedilol Generic | 100 | 216 | 24 | $1,371 |
| Allopurinol Generic | 69 | 183 | 22 | $694 |
| Spironolactone Generic | 66 | 158 | 21 | $515 |
| Lisinopril Generic | 66 | 174 | 18 | $752 |
| Kerendia Finerenone | 61 | 116 | 15 | $76K |
| Jardiance Empagliflozin | 56 | 144 | 19 | $82K |
| Calcium Acetate Generic | 52 | 125 | 24 | $5,919 |
| Prednisone Generic | 51 | 125 | 21 | $765 |
Brand drugs: - claims; generic drugs: 2,395 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Osama Amro $100K ($100K in general payments such as food, travel and fees) from 9 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $55K.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 53 | $55K |
| Novartis Pharmaceuticals Corporation NVS | 18 | $25K |
| Travere Therapeutics, Inc. TVTX | 22 | $12K |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 9 | $7,891 |
| Vantive US Healthcare LLC | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $101 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.